home / stock / kool / kool quote
Last: | $ |
---|---|
Change Percent: | -5.69% |
Open: | $6.45 |
Close: | $6.13 |
High: | $6.45 |
Low: | $5.88 |
Volume: | 101,682 |
Last Trade Date Time: | 10/15/2019 07:28:09 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $6.45 | $6.13 | $6.45 | $5.88 | 101,682 | 10-15-2019 |
$ | $6.50 | $6.57 | $6.62 | $6.3824 | 60,953 | 10-11-2019 |
$ | $6.16 | $6.35 | $6.44 | $6.16 | 67,739 | 10-10-2019 |
$ | $6.18 | $6.16 | $6.4071 | $5.85 | 116,481 | 10-09-2019 |
$ | $6.50 | $6.13 | $6.70 | $6.0601 | 128,091 | 10-08-2019 |
$ | $6.56 | $6.60 | $6.89 | $6.51 | 170,575 | 10-07-2019 |
$ | $6.36 | $6.51 | $6.5498 | $6.13 | 70,205 | 10-04-2019 |
$ | $6.36 | $6.28 | $6.6594 | $6.03 | 129,945 | 10-03-2019 |
$ | $6.34 | $6.16 | $6.54 | $6.01 | 124,822 | 10-02-2019 |
$ | $6.75 | $6.37 | $6.8994 | $6.35 | 216,477 | 10-01-2019 |
$ | $6.40 | $6.63 | $6.80 | $6.30 | 272,732 | 09-30-2019 |
$ | $5.92 | $6.39 | $7.00 | $5.86 | 331,428 | 09-27-2019 |
$ | $6.19 | $5.86 | $6.19 | $5.85 | 86,957 | 09-26-2019 |
$ | $5.95 | $6.20 | $6.29 | $5.80 | 207,438 | 09-25-2019 |
$ | $6.22 | $6.11 | $6.50 | $5.90 | 253,759 | 09-24-2019 |
$ | $5.43 | $6.40 | $6.75 | $5.43 | 508,219 | 09-23-2019 |
$ | $5.11 | $5.33 | $5.5787 | $4.9965 | 137,879 | 09-20-2019 |
$ | $4.66 | $5.10 | $5.20 | $4.53 | 115,489 | 09-19-2019 |
$ | $4.72 | $4.70 | $5.0999 | $4.50 | 220,643 | 09-18-2019 |
$ | $4.47 | $4.75 | $4.80 | $4.35 | 146,808 | 09-17-2019 |
News, Short Squeeze, Breakout and More Instantly...
Cesca Therapeutics Inc. Company Name:
KOOL Stock Symbol:
NASDAQ Market:
Cesca Therapeutics Inc. Website:
RANCHO CORDOVA, Calif. , Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order...
RANCHO CORDOVA, Calif. , Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu , Ph.D., Chairman and Chief Executive Officer, will present a...
RANCHO CORDOVA, Calif. , Oct. 22, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today announced that the company...